Skip to main content
Signal8

PALATIN TECHNOLOGIES INC (PTN)

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Palatin Technologies, Inc. logo

Palatin Technologies, Inc.

NASDAQ:PTNHealthcare
AH-1.12%$5.30
Close$5.36-12.49%
Mkt Cap$9.55M
EV-
Float1.69M
O/S1.78M
VOL53K sh
$ Vol$295K
RVOL1.28×
Inst Own55.5%
SI17.4%
Net Cash/Sh-
Dilution
Palatin Technologies, Inc. logoNASDAQ:PTNAH$5.30-1.12%
FormDescription
13G
Beneficial Ownership Report
10-Q
10-K
13G/A
Beneficial Ownership Report (Amended)
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
5.07,9.01
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
DEF 14A
Definitive Proxy Statement
CERT
SEC Filing
8-A12B
SEC Filing
25
SEC Filing
8-K
3.01,7.01,9.01
13G/A
Beneficial Ownership Report (Amended)
13G/A
Beneficial Ownership Report (Amended)
13G
Beneficial Ownership Report
10-Q
Quarterly Report
13G
Beneficial Ownership Report
10-Q
Quarterly Report
13G
Beneficial Ownership Report
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership

1-25 of 1,157

…

Recent SEC filings with analysis

    Palatin Technologies Inc. (PTN) SEC Filings: 10-K, 10-Q, 8-K | Signal8